and our own findings make it possible to construct a probable sequence of events in the hyperacute rejection process. The first change appears to be damage to the capillary endothelium presumably by an antibody antigen complex with subsequent binding of complement. This is followed by platelets adhering to the damaged endothelium and subsequent aggregation in the glomerular and peritubular capillaries. Substances released from these damaged platelets could result in the intense vasoconstriction, which together with the platelet plugs themselves could cause acute haemostasis and immediate rejection. Thrombosis is probably a later and secondary change.
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The action of heparin in prolonging graft survival is probably due to its direct effect on the platelets. This is consistent with our findings of a reduced fall in the platelet count in the heparintreated dogs. Linn et al. (1971) suggested that substances released by the breakdown of complement contribute to the vasoconstriction during acute rejection. For this reason we established that our heparin preparation was free from anticomplementary activity. Modification of the rejection process with aspirin or cyproheptadine hydrochloride (Periactin) could also be explained by their antagonism to platelet aggregation (O'Brien, 1968; Burrows et al., 1970) .
Introduction
In most cases of drug-induced blood dyscrasias identification of a causative agent can be made only from the patient's history. This is relatively easy in cases of single drug exposure but more difficult when several drugs are involved. Re-exposure of the patient to the drug cannot be justified as a diagnostic procedure, and firm proof of the harmful nature of a drug has until now been difficult to obtain. This paper reports a case of amodiaquine-induced agranulocytosis in which the toxic effect of amodiaquine was shown by its inhibition of colony growth of the A 26-year-old woman visited New Guinea for a two-week holiday in July 1972. Antimalarial prophylaxis consisting of amodiaquine (Camoquin) 300 mg once a week was started four weeks before her departure and continued during and after her holiday (see chart). She took a total of eight doses (2.4 g), the last one three days before her admission. She was febrile and unwell for two days after the second dose, and had diarrhoea for one day on her return, but had otherwise experienced no untoward symptoms. One week before admission she was vaccinated, and immunized against typhoid and cholera. Two days before admission she became febrile, with myalgia and night sweats. Her local doctor prescribed tetracycline and Actifed (triprolidine hydrochloride and pseudephedrine hydrocloride). When a blood count showed agranulocytosis, she was admitted to hospital.
She gave a history of five episodes of respiratory tract infection in the 18 months preceding admission, and she had noted increas- (table II) .
In the normal control amodiaquine-treated cultures formed significantly greater numbers of colonies than did untreated cultures (table II) .
By contrast, colony formation by the patient's bone marrow was significantly inhibited by a concentration of 0 5 jg/ml of amodiaquine, the effect being uniform for each of the five feeder layers used. The colonies formed were also smaller in size than normal, but no morphological abnormalities were discernible in aceto-orcein-stained preparations. Lower concentrations of amodiaquine (0 005 or 0 05 ,±g/ml) had no significant effect on colony formation by the patient's marrow.
Discussion
Of the 4-aminoquinolone antimalarials, amodiaquine (Love et al., 1953; Kennedy, 1955; Glick, 1957; Perry et al., 1962; Booth et al., 1967) and hydroxychloroquine (Polano et al., 1965; Chernof and Taylor, 1968) have been reported to cause agranulocytosis. Most of the reported cases have been associated with ingestion of relatively large doses; in only two other cases has agranulocytosis occurred after the dosage recommended for prophylaxis (cases 3 and 4, Booth et al., 1967) . The pharmacology of amodiaquine is similar to that of chloroquine (Love et al., 1953; Goodman and Gilman, 1970; Grollman and Grollman, 1970) . A plasma level of between 0-15 and 0-25 ,ug/ml would be expected after a single dose of 300 mg base, falling to between 0-02 and 0 04 vg/ml before the next dose one week later (Goodman and Gilman, 1970) . In addition, leucocytes, which concentrate chloroquine (Goodman and Gilman, 1970), probably also concentrate amodiaquine. The highest dose tested in vitro (0 5 ILg/ml) was selected to represent a possible bone marrow level after eight weeks' therapy, taking into account drug accumulation and concentration. The lower concentrations were included to test the possibility that the patient's cells were unduly sensitive to the drug.
The cells from which marrow colonies arise (colony-forming cells) are thought by most workers to be stem cells committed to granulopoiesis (Rickard et al., 1970; Lancet, 1972 Means which differ significantly (P < 0 001) from the mean untreated value for the same marrow sample.
Analysis of variance: patient F = 26-75, P < 0-001; control F .4 = 9-61, P <0 001.
Values are the numbers of coloies grown from plating 2 x 10' nucleated marrow celis. Individual values are the mean of triplicate cultures on each feeder layer.
BRrllSH MEDICAL JOURNAL 24 PBuARY 1973 that it be used to investigate other patients with agranulocytosis after exposure to possibly toxic drugs, particularly where more than one drug might be responsible. In the present case cultures were carried out after haematological recovery had occurred. Whether the technique can be used in the acute phase of marrow suppression will depend on the number of colonyforming cells present in the marrow.
Further studies of the patient at a longer interval after recovery, and of her family, are planned, and will be reported subsequently.
A case of Loffler's syndrome presenting with respiratory symptoms and a high eosinophilia is reported. Full investigation, including bone marrow biopsy, was carried out with negative results. Four months later further physical signs developed which led to a diagnosis of lymphosarcoma being established by lymph node and bone marrow biopsy. This is a rare finding, and in two extensive reviews of lymphoid tumours Lbffler's syndrome was not reported as the presenting clinical picture in lymphosarcoma.
Case Report
A previously healthy 4-year-old boy was admitted to the Royal Manchester Children's Hospital in December 1971. Two weeks before admission he had been treated for a dental abscess with lincomycin. This was discontinued after three days because he developed an urticarial rash. He then had two teeth extracted under general anaesthesia with tetracycline (Achromycin) cover. Two days before admission he was noted to be lethargic and to be sleeping more than usual. Later that day his respiration rate increased and he became flushed. These symptoms persisted until admission, by which time he had developed a dry cough and had vomited three times.
His birth and neonatal history were normal. Both parents and his 8-year-old sibling were well. He had never been abroad, and the family did not have any pets. On admission radiograph of the chest showed the presence of multiple diffuse nodular opacities throughout both lung fields (see fig.) . Other investigations were: haemoglobin 10-2 g/100 ml, total white cell count 35,000/mm3, differential count, eosinophils 71%, neutrophils 11%, lymphocytes 18%.
Chest radiograph showing multiple diffuse nodular opacities throughout lung fields.
His clinical condition rapidly deteriorated with increasing dyspnoea and cyanosis. His liver became palpable, and he complained of epigastric discomfort. The liver was smooth and nontender with a firm consistency. He was, therefore, nursed in an oxygen tent and given corticosteroid therapy. He improved on this treatment, the epigastric pain eased, and his respiratory symptoms became less severe. The liver gradually diminished in size over a two-week period.
The following tests were carried out shortly after his admission and while he was receiving steroid therapy: E.S.R. 40 mm in the first hour. Liver function tests, the blood urea, serum electrolytes, serum calcium, and serum phosphate were all within normal limits. Cultures of blood, urine, stool, nasal and throat swabs did not show any pathogenic organism. No acid-fast bacilli, worms, or ova were found in gastric washings or in repeated stool specimens. Protein electrophoresis showed an increase in a2 globulin: serum
